6533b7d2fe1ef96bd125ea2e

RESEARCH PRODUCT

Polymorphism of Amyloid Fibrils and their Complexes with Catalase

J. Robin HarrisNathaniel G.n. Milton

subject

geographyHuntingtingeography.geographical_feature_categorybiologyP3 peptideIsletnervous system diseaseschemistry.chemical_compoundKisspeptinschemistryPolymorphism (materials science)BiochemistryCatalasemental disordersHuntingtin Proteinbiology.proteinEthylene glycol

description

Catalase binding to amyloid fibrils has been shown for the Alzheimer’s amyloid-β (Aβ), type 2 diabetes-associated islet amyloid polypeptide (IAPP) and Creutzfeldt-Jakob disease-associated prion protein (PrP). Catalase targets a specific domain with a GAII-like sequence and there are a number of other amyloid fibril-forming proteins that contain related sequences, such as the Parkinson’s associated α-synuclein protein and the Huntington disease protein Huntingtin. Using transmission electron microscopy (TEM) analysis, interactions show specific binding of catalase to some, but not all, fibrillar forms of Aβ, IAPP and PrP fragments, allowing determination of the fibrillar forms that contain an accessible GAII-like sequence. The catalase–amyloid interactions have been used to identify novel amyloid-binding compounds such as the kisspeptins and oligo(ethylene glycol) derivatives of 6-methylbenzothiazole aniline. The use of TEM and other imaging techniques to study amyloid–catalase interactions has the potential for discovery of new therapeutics for amyloid-associated disorders.

https://doi.org/10.1016/b978-0-12-394431-3.00023-7